首页 › 基金 › Bellevue Group AG › JBIO

Bellevue Group AG 对 JBIO 的持仓历史

JADE BIOSCIENCES INC · 医疗保健

Bellevue Group AG 在 Q2 2026 的 13F 申报中披露持有 JBIO(JADE BIOSCIENCES INC)3,057,996 股,市值约 US$67.9M,约占其申报组合的 1.43%,在其申报持仓中市值排名第 25 位。 Bellevue Group AG 最近 3 个申报季度中有 3 个季度披露了 JBIO 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)3.06M 股
申报持仓市值$67.95M
组合权重1.43%
首次申报Q4 2025
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Bellevue Group AG 对 JBIO 的持仓演变

Bellevue Group AG 于 Q4 2025 首次披露 JBIO 持仓:3,341,103 股(约 US$51.6M)。 该持仓在 Q2 2026 达到峰值 3,057,996 股,市值约 US$67.9M。 在 3 次申报中,Bellevue Group AG 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 3,057,996 股、市值约 US$67.9M,环比减持 -443,506 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 3.34M $51.55M 新进
Q1 2026 3.50M $49.20M 增持
Q2 2026 3.06M $67.95M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 JBIO 与 13F 数据

JBIO(JADE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 106 只申报持有 JBIO,申报仓位最大的包括:Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 JBIO 的基金

查看 JBIO 的全部基金持有人 →

常见问题

How long has Bellevue Group AG held JBIO?

Bellevue Group AG has disclosed JBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Bellevue Group AG's current position in JBIO?

As of Q2 2026, Bellevue Group AG holds 3.06M shares of JBIO (JADE BIOSCIENCES INC), valued at $67.95M, representing 1.43% of its reported portfolio and ranking #25.

Has Bellevue Group AG been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in JBIO. The position peaked in Q2 2026 at 3.06M shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.